[{"AccountsPayableCurrent_0_Q1_USD":26595000.0,"AccruedRoyaltiesCurrent_0_Q1_USD":6400000.0,"PrepaidExpenseNoncurrent_0_Q1_USD":5164000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":10248000.0,"LiabilitiesFairValueDisclosure_0_Q1_USD":5200000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":18993000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":24024000.0,"OtherAssetsMiscellaneousNoncurrent_0_Q1_USD":2415000.0,"OtherNonoperatingExpense_1_Q1_USD":7420000.0,"OtherLiabilitiesCurrent_0_Q1_USD":12463000.0,"IncreaseDecreaseInOtherOperatingAssets_1_Q1_USD":27966000.0,"ShortTermInvestments_0_Q1_USD":406940000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":1772777000.0,"PrepaidInsurance_0_Q1_USD":1420000.0,"OtherAssetsCurrent_0_Q1_USD":96153000.0,"PrepaidTaxes_0_Q1_USD":5303000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":574000.0,"InventoryFinishedGoodsNetOfReserves_0_Q1_USD":6911000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":7482000.0,"InvestmentIncomeInterest_1_Q1_USD":2139000.0,"IncrementalCommonSharesAttributableToCallOptionsAndWarrants_1_Q1_shares":0.0,"DepreciationDepletionAndAmortization_1_Q1_USD":6529000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q1_USD":574000.0,"IncreaseDecreaseInDeferredRevenue_1_Q1_USD":820437000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-16918000.0,"CashEquivalentsAtCarryingValue_0_Q1_USD":1359868000.0,"AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_1_Q1_USD":24024000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":3455689000.0,"AssetsFairValueDisclosure_0_Q1_USD":1801506000.0,"AvailableForSaleSecuritiesTransfersToTradingGrossGains_1_Q1_USD":108069000.0,"RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_1_Q1_USD":13226000.0,"RestrictedCashNoncurrent_0_Q1_USD":8565000.0,"RestrictedCashAndInvestmentsNoncurrent_0_Q1_USD":9566000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_1_Q1_USD":136144000.0,"ProceedsFromSaleOfIntangibleAssets_1_Q1_USD":108069000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_1_Q1_USD":250000000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_1_Q1_USD":365437000.0,"OtherNoncashIncomeExpense_1_Q1_USD":1381000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest_1_Q1_USD":574000.0,"OtherAssetsMiscellaneousCurrent_0_Q1_USD":5867000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":63097000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":65263000.0,"NumberOfOperatingSegments_1_Q1_Segment":1.0,"NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_1_Q1_USD":6154000.0,"LongTermLoansPayable_0_Q1_USD":687953000.0,"InventoryWorkInProcessAndRawMaterialsNetOfReserves_0_Q1_USD":84521000.0,"InventoryRawMaterialsNetOfReserves_0_Q1_USD":81736000.0,"GovernmentContractReceivable_0_Q1_USD":470000.0,"GainLossOnDispositionOfIntangibleAssets_1_Q1_USD":108069000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q1_USD":732667000.0,"ContractWithCustomerLiabilityCurrent_0_Q1_USD":91073000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":929132000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q1_USD":1772777000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q1_USD":2180700000.0,"BilledContractReceivables_0_Q1_USD":89960000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q1_USD":406940000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":100448000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":8214000.0,"OtherAssetsNoncurrent_0_Q1_USD":186805000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":137325000.0,"ProfitLoss_1_Q1_USD":-17492000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":9120000.0,"NetIncomeLoss_1_Q1_USD":-17492000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":627790000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-17680000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":319022000.0,"LiabilitiesCurrent_0_Q1_USD":306429000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":2947388000.0,"Liabilities_0_Q1_USD":1802560000.0,"InventoryNet_0_Q1_USD":173168000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":15996000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":115000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":-17377000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.23,"CostsAndExpenses_1_Q1_USD":231700000.0,"CommonStockValue_0_Q1_USD":8000.0,"CommonStockSharesOutstanding_0_Q1_shares":77957790.0,"CommonStockSharesIssued_0_Q1_shares":77957790.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":1764212000.0,"AssetsCurrent_0_Q1_USD":2547348000.0,"Assets_0_Q1_USD":2947388000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":10500000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":624000.0,"AccountsReceivableNetCurrent_0_Q1_USD":106875000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-2311493000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":76432000.0,"Revenues_1_Q1_USD":113674000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":76432000.0,"NonoperatingIncomeExpense_1_Q1_USD":100649000.0,"BusinessCombinationContingentConsiderationLiability_0_Q1_USD":5200000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":1092000.0,"FiniteLivedIntangibleAssetsNet_0_Q1_USD":12813000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":11219000.0,"IncreaseDecreaseInInventories_1_Q1_USD":1789000.0,"AmortizationOfIntangibleAssets_1_Q1_USD":166000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q1_USD":50868000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":76432000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":3687000.0,"ShareBasedCompensation_1_Q1_USD":24024000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":82768000.0,"PreferredStockValue_0_Q1_USD":null,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"PreferredStockSharesAuthorized_0_Q1_shares":3333333.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"OperatingIncomeLoss_1_Q1_USD":-118026000.0,"InterestPayableCurrent_0_Q1_USD":3183000.0,"InterestPaidNet_1_Q1_USD":5385000.0,"InterestExpense_1_Q1_USD":13615000.0,"CommonStockSharesAuthorized_0_Q1_shares":99000000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"CommitmentsAndContingencies_0_Q1_USD":null,"AccruedLiabilitiesCurrent_0_Q1_USD":176298000.0,"StockholdersEquity_0_Q1_USD":1144828000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q1_USD":3795000.0,"Ticker":"SRPT","CIK":"873303","name":"SAREPTA THERAPEUTICS, INC.","OfficialName":"Sarepta Therapeutics Inc. Common Stock (DE)","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"7117506934.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200506"}]